A systematic review of economic analyses of HER2 testing & trastuzumab therapy

被引：0
|
作者：
Ferrusi, I. L. [1 ]
Marshall, D. A. [1 ]
Kulin, N. A. [1 ]
Phillips, K. A. [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70194-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [21] TRASTUZUMAB AS A THERAPY VERSUS OTHER TREATMENT REGIMENS IN PATIENTS WITH HER2 POSITIVE BREAST CANCER: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
    Yerram, S. K.
    Gadi, H. R.
    Kethireddy, K.
    Thatavarti, R.
    VALUE IN HEALTH, 2017, 20 (09) : A418 - A418
  • [22] HER2/neu in systemic therapy for women with breast cancer:: a systematic review
    Dhesy-Thind, Bindi
    Pritchard, Kathleen I.
    Messersmith, Hans
    O'Malley, Frances
    Elavathil, Leela
    Trudeau, Maureen
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) : 209 - 229
  • [23] Looking for Her (2+): A systematic review of the economic evaluations of Trastuzumab in early stage HER 2 positive breast cancer
    Petrou, Panagiotis
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (02) : 115 - 125
  • [24] Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer (MBC) patients in Sweden
    Lidgren, M.
    Rehnberg, C.
    Wilking, N.
    Jonsson, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Use of total HER2 and HER2 homodimer levels to predict response to trastuzumab
    Leitzel, K.
    Lipton, A.
    Koestler, W.
    Fuchs, E.
    Ali, S. M.
    Weidler, J.
    Wu, Y.
    Sperinde, J.
    Huang, W.
    Bates, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Dual targeting of HER2 with lapatinib and trastuzumab
    Joensuu, Heikki
    LANCET ONCOLOGY, 2014, 15 (10): : 1050 - 1052
  • [27] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    LABORATORY INVESTIGATION, 2011, 91 : 62A - 62A
  • [28] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    MODERN PATHOLOGY, 2011, 24 : 62A - 62A
  • [29] Maintenance Therapy with Trastuzumab in Her2 Positive Metastatic Parotid Ductal Adenocarcinoma
    Iqbal, Muhammad Shahid
    Shaikh, Ghazia
    Chatterjee, Sanjoy
    Cocks, Helen
    Kovarik, Josef
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [30] HER2 signaling pathway and trastuzumab cardiotoxicity
    Criscitiello, Carmen
    Curigliano, Giuseppe
    FUTURE ONCOLOGY, 2013, 9 (02) : 179 - 181
12345